Belantamab mafodotin
Product Sizes
5 mg
£ POA
HY-P3239-5MG
1 mg
£ POA
HY-P3239-1MG
10 mg
£ POA
HY-P3239-10MG
25 mg
£ POA
HY-P3239-25MG
50 mg
£ POA
HY-P3239-50MG
100 mg
£ POA
HY-P3239-100MG
About this Product
- SKU:
- HY-P3239
- Additional Names:
- GSK2857916; Belantamab mafodotin-blm
- Application:
- Antibody Microarray
- CAS Number:
- 2050232-20-5
- Extra Details:
- Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. The antibody portion is Belantamab (HY-P9980); and the drug-linker conjugate for ADC is McMMAF (HY-15578). Belantamab mafodotin has anti-myeloma activity[1][2].
- Molecular Weight:
- 149000 (average)
- Purity:
- 99.78
- References:
- [1]Hulin C, et al. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study. Lancet Oncol. 2020 Feb;21(2):207-221.|[2]Markham A. Belantamab Mafodotin: First Approval. Drugs. 2020 Oct;80(15):1607-1613.
- Research Area:
- Cancer
- Shipping Conditions:
- Dry Ice
- Storage Conditions:
- -80[o]C; protect from light
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Conjugated Protein
- Pathway:
- Antibody-drug Conjugate/ADC Related
